Antonios Valachis

1.7k total citations
75 papers, 912 citations indexed

About

Antonios Valachis is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonios Valachis has authored 75 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 29 papers in Cancer Research and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonios Valachis's work include Breast Cancer Treatment Studies (25 papers), Cancer Immunotherapy and Biomarkers (10 papers) and HER2/EGFR in Cancer Research (8 papers). Antonios Valachis is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Cancer Immunotherapy and Biomarkers (10 papers) and HER2/EGFR in Cancer Research (8 papers). Antonios Valachis collaborates with scholars based in Sweden, Greece and Spain. Antonios Valachis's co-authors include George Samonis, Diamantis P. Kofteridis, Sofia Maraki, Theodoros Foukakis, Dimitra Dimopoulou, Dimitrios Georgopoulos, Christina Alexopoulou, Ioannis Zerdes, Alexios Matikas and Jonas Bergh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Antonios Valachis

66 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonios Valachis Sweden	16	398	187	179	159	120	75	912
Lucie Biard France	22	260 0.7×	202 1.1×	78 0.4×	560 3.5×	46 0.4×	74	1.4k
Charu Taneja United States	15	219 0.6×	110 0.6×	88 0.5×	85 0.5×	36 0.3×	38	945
Nikolaos Andreatos United States	24	998 2.5×	444 2.4×	138 0.8×	308 1.9×	96 0.8×	60	2.0k
Hans Salwender Germany	23	617 1.6×	254 1.4×	34 0.2×	135 0.8×	25 0.2×	66	1.7k
Wensen Chen China	15	185 0.5×	341 1.8×	67 0.4×	78 0.5×	21 0.2×	49	946
Clyde D. Ford United States	19	343 0.9×	174 0.9×	50 0.3×	82 0.5×	52 0.4×	47	1.1k
Francesc Fernández‐Avilés Spain	24	532 1.3×	337 1.8×	43 0.2×	95 0.6×	57 0.5×	89	1.8k
Erin Jensen United States	20	1.4k 3.5×	245 1.3×	160 0.9×	861 5.4×	104 0.9×	53	2.1k
Cristina Royo Spain	19	271 0.7×	219 1.2×	78 0.4×	244 1.5×	20 0.2×	37	1.2k
Joseph Chan United States	16	363 0.9×	183 1.0×	127 0.7×	152 1.0×	20 0.2×	40	915

Countries citing papers authored by Antonios Valachis

Since Specialization

Citations

This map shows the geographic impact of Antonios Valachis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios Valachis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios Valachis more than expected).

Fields of papers citing papers by Antonios Valachis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios Valachis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios Valachis. The network helps show where Antonios Valachis may publish in the future.

Co-authorship network of co-authors of Antonios Valachis

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios Valachis. A scholar is included among the top collaborators of Antonios Valachis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios Valachis. Antonios Valachis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zerdes, Ioannis, Antonio D’Alessio, Theodoros Foukakis, et al.. (2025). Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation. JNCI Journal of the National Cancer Institute. 117(6). 1117–1124. 3 indexed citations

Kastora, Stavroula, Eirini Pantiora, Hatem A. Azim, et al.. (2025). Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion. Cancer Treatment Reviews. 133. 102880–102880. 3 indexed citations

Lambertini, Matteo, et al.. (2025). Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey. The Breast. 81. 104456–104456.

Karakatsanis, Andreas, Anne Andersson, Zakaria Einbeigi, et al.. (2024). 339TiP A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE). Annals of Oncology. 35. S356–S356. 1 indexed citations

Ivanović, Mirjana, et al.. (2024). Towards optimal learning: Investigating the impact of different model updating strategies in federated learning. Expert Systems with Applications. 249. 123553–123553. 6 indexed citations

Derksen, Jeroen W. G., Diogo Martins-Branco, Antonios Valachis, et al.. (2024). Real-world evidence reported for clinical efficacy evaluation in European Public Assessment Reports of authorised targeted therapies for solid malignancies: a comprehensive review (2018-2022). SHILAP Revista de lepidopterología. 4. 100039–100039. 5 indexed citations

Valachis, Antonios, Henrik Lindman, Daniel R. Smith, et al.. (2024). Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer. JNCI Journal of the National Cancer Institute. 117(6). 1125–1133.

Pellat, Anna, Thomas Grinda, Arsela Prelaj, et al.. (2024). Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours. SHILAP Revista de lepidopterología. 6. 100091–100091. 1 indexed citations

Koliadi, Anthoula, et al.. (2024). Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness. Frontiers in Oncology. 14. 1399171–1399171. 8 indexed citations

10.

Fredriksson, Irma, et al.. (2023). Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. 203(2). 235–243. 1 indexed citations

11.

Smith, Daniel R., et al.. (2023). Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study. Breast Cancer Research and Treatment. 204(1). 79–87. 3 indexed citations

12.

Pellat, Anna, Thomas Grinda, Arsela Prelaj, et al.. (2023). 1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and Digital Health Working Group. Annals of Oncology. 34. S925–S925. 5 indexed citations

13.

Koliadi, Anthoula, et al.. (2023). Predicting immune‐related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study. Cancer Medicine. 12(12). 13217–13224. 6 indexed citations

14.

Rodriguez‐Wallberg, Kenny A., Hanna Nilsson, Jonas Bergh, et al.. (2023). ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden—a phase III randomised double-blinded placebo-controlled study. BMJ Open. 13(12). e078023–e078023. 5 indexed citations

15.

Koliadi, Anthoula, et al.. (2023). The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis. Pigment Cell & Melanoma Research. 37(3). 352–362. 7 indexed citations

16.

Valachis, Antonios, et al.. (2023). Intraoperative Radiation Therapy Delivered by Brachytherapy in Breast Cancer: An Interim Analysis of a Phase 2 Trial. Clinical Breast Cancer. 24(3). 243–252. 1 indexed citations

17.

Garcia‐Argibay, Miguel, Hans Garmo, Johan Ahlgren, et al.. (2021). Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study. The Breast. 59. 157–164. 28 indexed citations

18.

Matikas, Alexios, Ioannis Zerdes, John Lövrot, et al.. (2019). Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data. Clinical Cancer Research. 25(18). 5717–5726. 73 indexed citations

19.

Valachis, Antonios, et al.. (2019). Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome. Acta Oncologica. 58(8). 1170–1177. 13 indexed citations

20.

Kofteridis, Diamantis P., et al.. (2009). Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. International Journal of Infectious Diseases. 14(6). e489–e493. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact